Navigation Links
Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
Date:2/23/2011

tual property news, Silence also announces the issuance of United States patent 7,893,243, titled "Composition and Methods of RNAi Therapeutics for Treatment of Cancer and Other Neovascularization Diseases," by the United States Patent and Trademark Office (USPTO).  This issued patent is broadly directed to a double stranded, double blunt ended siRNA sequence against the validated cancer target vascular endothelial growth factor (VEGF).  VEGF has been demonstrated to play an important role in the underlying causes of various cancers including abnormal angiogenesis and uncontrolled cell division.  The active pharmaceutical ingredient covered by the issued patent is a potent 25mer siRNA, with or without chemical modification, further demonstrating Silence's continued ability to secure meaningful intellectual property protection for its portfolio of 25mer sequences.  

Silence Therapeutics is executing a proactive strategy to continue to build and strengthen a global, diverse and competitive intellectual property portfolio that provides the Company and its partners with a strong proprietary position in the RNAi therapeutics space.  The Company believes that it will continue to make significant progress in these efforts as it expects additional RNAi patents to be issued in Japan, the United States and Europe during 2011.  At present, Silence's global patent portfolio contains issued patents and pending applications covering strategic areas of RNAi therapeutic development including multiple proprietary siRNA delivery technologies, potent siRNA sequences specific for high-value disease targets and key RNAi sequence and chemical modifications.

Notes for editors

About Silence Therapeutics plc (www.silence-therapeutics.com)

Silence Therapeutics plc (AIM: SLN) is a leading global biotechnology company dedicated to the discovery, development and deli
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics Provides Year-end Update
2. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
3. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
4. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
5. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
6. Silence Therapeutics Announces Board Changes
7. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
8. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
9. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
10. Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
11. Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... , April 30, 2015  Accuray Incorporated ... has signed an agreement with MIM Software Inc. ... TomoTherapy ® and CyberKnife ® product portfolios. ... and MIM technology. This is Accuray,s second collaboration ... development of the first iPad-based treatment plan review ...
(Date:4/30/2015)... DIEGO, April 30, 2015  Tandem Diabetes Care ® , ... manufacturer of the t:slim ® and t:flex™ Insulin Pumps, ... 31, 2015. In comparing the first quarter ... Sales grew 53 percent to $12.3 million from $8.1 million ... pumps from 1,723 pumps "Our investment in resources ...
(Date:4/30/2015)...   Regulus Therapeutics Inc . (NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that it ... ended March 31, 2015 on Thursday, May 7, 2015, ... Regulus will host a conference call and webcast on ... Time to discuss its first quarter 2015 financial results ...
Breaking Medicine Technology:Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
... 2011 /PRNewswire-Asia/ -- Pharmaceutical company Hatchtech Pty Ltd has ... study to confirm the efficacy of its novel head ... is evaluating the efficacy, safety and tolerability of two ... to vehicle. The trial consists of treating 132 healthy ...
... Aug. 31, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... appointed Helen Torley, M.B. Ch. B., M.R.C.P.,  as Executive ... Dr. Torley will report to N. Anthony Coles, M.D., ... for all commercial activities related to Nexavar and the ...
Cached Medicine Technology:Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 2Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 3Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 2Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 3
(Date:5/3/2015)... Bubbly Walrus ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... to play on smartphones are the ones that get users ... a video game that just absorbs attention, why not exercise ...
(Date:5/3/2015)... Looking for a graduate business ... your career? The Master of International Business, executive ... multinational companies and for professionals seeking a career ... landscape, differences in culture, religion, government, and geography ... develops the global competence and confidence needed to ...
(Date:5/3/2015)... is not too late to register to take part in the ... Been in Arnold, Missouri on May 9, 2015. Family and ... loving memory. It has benefited the renowned Brain Aneurysm Foundation each ... suffered a brain aneurysm . After two operations and five ... designed to serve as a remembrance of her and to help ...
(Date:5/2/2015)... Vegas, NV (PRWEB) May 02, 2015 Ticket ... Pacquiao tickets for the long awaited event today, Saturday, ... Vegas. Diehard boxing fans will be able to secure ... events. , The fight that boxing fans have wanted for ... few months ago. Floyd “Money” Mayweather will step inside the ...
(Date:5/2/2015)... Aliso Viejo, CA (PRWEB) May 02, 2015 ... made exclusively for use in Final Cut Pro X. ... ready for use in Final Cut Pro X . ... a single keyframe with Pixel Film Studios' ProText Kinetic 2. ... drop. Start by staggering two ProText Kinetic presets in ...
Breaking Medicine News(10 mins):Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2
... demonstrated their,desire to be good neighbors during Aurora Health Care,s ... throughout eastern Wisconsin. , ... the event Saturday. The items were brought by nearly 1,200,residents ... clinics. , Good Neighbor ...
... 18 Capital BlueCross received the,2008 Corporation of the ... of Fundraising Professionals during a celebration of National,Philanthropy Day ... daily,contributions made by corporations, individuals, foundations and volunteers. , ... headquartered in central Pennsylvania, Capital BlueCross,remains part of the ...
... scientists, Wound-Be-Gone is now the only over the counter treatment for ... technology that both prevents contamination of wounds and speeds up the ... ... --- Now, with the development of Wound-Be-Gone, all skin injuries, especially ...
... anti-disease effect in postmenopausal women, study says , , TUESDAY, ... found out why diet and exercise affect a women,s ... new study says. , Researchers at the University ... exercise affect pathways to mTOR, a molecule that integrates ...
... nontoxic nanoparticle developed by Penn State researchers is proving ... therapeutic drugs and the fluorescent dyes that can track ... Nano Letters , an interdisciplinary group of materials ... phosphate particles ranging in size from 20 to 50 ...
... FRANCISCO, Nov. 18 State Compensation Insurance Fund,today announced it ... business disruption caused by the fires in Montecito, Orange,County and ... more than 900 residences and structures have been lost due ... untold number of businesses,have suffered damages. , ...
Cached Medicine News:Health News:Eastern Wisconsin Residents Demonstrate Their Commitment to Being Good Neighbors 2Health News:Eastern Wisconsin Residents Demonstrate Their Commitment to Being Good Neighbors 3Health News:Capital BlueCross Receives Prestigious Corporation of the Year Award 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 3Health News:Diet, Exercise May Modify Breast Cancer Risks 2Health News:Nontoxic nanoparticle can deliver and track drugs 2Health News:Nontoxic nanoparticle can deliver and track drugs 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: